Discovery of Ptr gene revolutionizes understanding of plant immunity against fungal infections

Blast disease, caused by the fungus Magnaporthe oryzae, is a veritable plague in agriculture. In addition to devastating rice crops – the staple food of 60% of the world's population – it began attacking wheat in the 1980s, across a growing area of distribution and with a serious risk of emergence in Europe. 

In this context, researchers from INRAE, CIRAD and the Université de Montpellier, together with scientists from China and the Philippines, analysed the molecular mechanisms behind a natural resistance to blast found in rice. They identified Ptr, a new type of disease resistance gene in plants. The presence of this Ptr gene makes rice immune to strains of M. oryzae that secrete AVR-Pita virulence factor, a protein that, in the absence of this gene, helps the pathogenic fungus invade the plant.

The majority of resistance genes in plants code for antenna-like receptors (proteins) that recognise chemical signals emitted by pathogens.

Ptr, however, codes for a new type of protein, not previously known to be active in plant immune systems. Scientists do not yet understand how this protein works. Unexpectedly, this research invalidates previous reference studies, published in 2000, that reported that another gene named Pi-ta and coding for a conventional type of immune receptor was responsible for AVR-Pita detection.

This work paves the way to the study of new resistance mechanisms in plants based on Ptr protein and other new components, with the aim of better understanding natural resistance to disease and using it more effectively for crop protection.

Source:
Journal reference:

Xiao, G., et al. (2024). The unconventional resistance protein PTR recognizes the Magnaporthe oryzae effector AVR-Pita in an allele-specific manner. Nature Plants. doi.org/10.1038/s41477-024-01694-z

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
StitchR technology delivers large genes for muscular dystrophy treatment